Details for: FUS

Gene ID: 2521

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: FUS

Ensembl ID: ENSG00000089280

Description: FUS RNA binding protein

Cell Significance Landscape

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • hematopoietic stem cell CL0000037
    CSI 90.81
    rCSI 60.36%
    PRS 4.96
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 86.27
    rCSI 77.91%
    PRS 3.67
  • fallopian tube secretory epithelial cell CL4030006
    CSI 80.28
    rCSI 77.28%
    PRS 4.3
  • common myeloid progenitor CL0000049
    CSI 79.64
    rCSI 64.39%
    PRS 4.09
  • CD4-positive helper T cell CL0000492
    CSI 78.36
    rCSI 59.28%
    PRS 5.85
  • granulocyte monocyte progenitor cell CL0000557
    CSI 74.89
    rCSI 64.85%
    PRS 4.63
  • keratinocyte CL0000312
    CSI 72.15
    rCSI 60.48%
    PRS 5
  • fraction A pre-pro B cell CL0002045
    CSI 70.31
    rCSI 80.48%
    PRS 8.67
  • pro-B cell CL0000826
    CSI 69.44
    rCSI 57.5%
    PRS 4.16
  • common dendritic progenitor CL0001029
    CSI 67.08
    rCSI 84.19%
    PRS 5.29
  • plasmacytoid dendritic cell, human CL0001058
    CSI 61.6
    rCSI 43.01%
    PRS 4.39
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 60.51
    rCSI 45.37%
    PRS 12.65
  • early lymphoid progenitor CL0000936
    CSI 60.3
    rCSI 52.96%
    PRS 4.66
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 60.02
    rCSI 40%
    PRS 11.75
  • intestinal epithelial cell CL0002563
    CSI 58.26
    rCSI 60.89%
    PRS 4.42
  • epithelial cell of lung CL0000082
    CSI 57.91
    rCSI 48.01%
    PRS 3.89
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 56.87
    rCSI 43.82%
    PRS 3.76
  • common lymphoid progenitor CL0000051
    CSI 55.65
    rCSI 74.37%
    PRS 7.99
  • stem cell CL0000034
    CSI 52.72
    rCSI 50.83%
    PRS 2.11
  • peripheral nervous system neuron CL2000032
    CSI 49.4
    rCSI 67.31%
    PRS 3.76
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 48.91
    rCSI 49.85%
    PRS 6.04
  • mature B cell CL0000785
    CSI 45.46
    rCSI 39.52%
    PRS 5.13
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 45.18
    rCSI 30.44%
    PRS 5.06
  • enteric smooth muscle cell CL0002504
    CSI 43.92
    rCSI 62.68%
    PRS 4.74
  • transit amplifying cell of colon CL0009011
    CSI 43.42
    rCSI 51%
    PRS 5.04
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 43.05
    rCSI 30.23%
    PRS 12.55
  • promyelocyte CL0000836
    CSI 41.52
    rCSI 59.88%
    PRS 5.79
  • group 3 innate lymphoid cell CL0001071
    CSI 40.62
    rCSI 30.52%
    PRS 4.29
  • extravillous trophoblast CL0008036
    CSI 40.38
    rCSI 49.95%
    PRS 3.64
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 37.9
    rCSI 45.93%
    PRS 6.28
  • myeloid leukocyte CL0000766
    CSI 37.39
    rCSI 34.5%
    PRS 4.21
  • double negative thymocyte CL0002489
    CSI 35.64
    rCSI 24.78%
    PRS 4.89
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 34.31
    rCSI 20.27%
    PRS 5.83
  • memory B cell CL0000787
    CSI 34
    rCSI 33.57%
    PRS 18.38
  • mesodermal cell CL0000222
    CSI 33.28
    rCSI 39.94%
    PRS 4.16
  • neural crest cell CL0011012
    CSI 31.77
    rCSI 25.11%
    PRS 2.87
  • colon epithelial cell CL0011108
    CSI 30.74
    rCSI 32.2%
    PRS 3.88
  • precursor B cell CL0000817
    CSI 30.59
    rCSI 26.8%
    PRS 5.63
  • OFF-bipolar cell CL0000750
    CSI 29.81
    rCSI 40.76%
    PRS 7.28
  • stromal cell of ovary CL0002132
    CSI 29.24
    rCSI 80.35%
    PRS 6.96
  • large pre-B-II cell CL0000957
    CSI 29.14
    rCSI 83.18%
    PRS 7.39
  • respiratory suprabasal cell CL4033048
    CSI 28.94
    rCSI 37.12%
    PRS 4.8
  • T-helper 1 cell CL0000545
    CSI 27.88
    rCSI 50.32%
    PRS 12.73
  • thymocyte CL0000893
    CSI 27.69
    rCSI 98.4%
    PRS 13.63
  • ciliated epithelial cell CL0000067
    CSI 27.28
    rCSI 23.99%
    PRS 3
  • promonocyte CL0000559
    CSI 26.95
    rCSI 46.18%
    PRS 5.57
  • mature T cell CL0002419
    CSI 26.4
    rCSI 20.54%
    PRS 6
  • BEST4+ enteroycte CL4030026
    CSI 25.87
    rCSI 32.18%
    PRS 4.44
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 25.33
    rCSI 29.25%
    PRS 3.77
  • pancreatic A cell CL0000171
    CSI 25.27
    rCSI 26.47%
    PRS 4.45
  • microcirculation associated smooth muscle cell CL0008035
    CSI 24.64
    rCSI 71.32%
    PRS 4.71
  • class switched memory B cell CL0000972
    CSI 24.61
    rCSI 18.37%
    PRS 7.07
  • transitional stage B cell CL0000818
    CSI 24.48
    rCSI 80.13%
    PRS 13.07
  • transit amplifying cell CL0009010
    CSI 24.47
    rCSI 37.43%
    PRS 6.81
  • small intestine goblet cell CL1000495
    CSI 24.43
    rCSI 53.52%
    PRS 5.77
  • forebrain radial glial cell CL0013000
    CSI 24.28
    rCSI 77.9%
    PRS 6.25
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 23.76
    rCSI 64.05%
    PRS 5.42
  • intestine goblet cell CL0019031
    CSI 23.72
    rCSI 21.06%
    PRS 4.17
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 22.87
    rCSI 89.02%
    PRS 6.92
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 22.61
    rCSI 38.69%
    PRS 9.13
  • naive thymus-derived CD4-positive, alpha-beta T cell CL0000895
    CSI 22.59
    rCSI 28.39%
    PRS 22.39
  • pancreatic D cell CL0000173
    CSI 22.24
    rCSI 21.88%
    PRS 4.56
  • conventional dendritic cell CL0000990
    CSI 21.49
    rCSI 17.94%
    PRS 13.48
  • interstitial cell of Cajal CL0002088
    CSI 21.15
    rCSI 26.93%
    PRS 4.85
  • radial glial cell CL0000681
    CSI 20.88
    rCSI 29%
    PRS 4.36
  • placental villous trophoblast CL2000060
    CSI 20.49
    rCSI 31.66%
    PRS 3.9
  • naive B cell CL0000788
    CSI 19.71
    rCSI 16.9%
    PRS 11.75
  • mammary gland epithelial cell CL0002327
    CSI 19.62
    rCSI 68.84%
    PRS 7.57
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 19.47
    rCSI 32.69%
    PRS 2.55
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 18.93
    rCSI 97.74%
    PRS 8.33
  • luminal epithelial cell of mammary gland CL0002326
    CSI 18.89
    rCSI 34.32%
    PRS 6.37
  • epithelial cell CL0000066
    CSI 18.63
    rCSI 28.62%
    PRS 6.01
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 18.4
    rCSI 19.22%
    PRS 13.43
  • colon goblet cell CL0009039
    CSI 18.29
    rCSI 43.49%
    PRS 6.34
  • gamma-delta T cell CL0000798
    CSI 18.12
    rCSI 21.28%
    PRS 39.63
  • small pre-B-II cell CL0000954
    CSI 17.96
    rCSI 17.27%
    PRS 9.1
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 17.84
    rCSI 33.73%
    PRS 9.39
  • T-helper 17 cell CL0000899
    CSI 17.84
    rCSI 14.16%
    PRS 7.43
  • mesenchymal cell CL0008019
    CSI 17.82
    rCSI 45.26%
    PRS 4.26
  • enteroendocrine cell CL0000164
    CSI 17.11
    rCSI 23.37%
    PRS 4.6
  • deuterosomal cell CL4033044
    CSI 17.06
    rCSI 57.66%
    PRS 7.18
  • unswitched memory B cell CL0000970
    CSI 16.96
    rCSI 14.27%
    PRS 7.01
  • plasmacytoid dendritic cell CL0000784
    CSI 16.9
    rCSI 17.12%
    PRS 27.22
  • mucous neck cell CL0000651
    CSI 16.9
    rCSI 24.35%
    PRS 6.75
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 16.57
    rCSI 22.57%
    PRS 10.52
  • immature B cell CL0000816
    CSI 16.46
    rCSI 12.23%
    PRS 6.23
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 16.25
    rCSI 12.36%
    PRS 5.54
  • T follicular helper cell CL0002038
    CSI 16.2
    rCSI 12.12%
    PRS 6.85
  • transit amplifying cell of small intestine CL0009012
    CSI 16.02
    rCSI 70.32%
    PRS 8.14
  • multi-ciliated epithelial cell CL0005012
    CSI 15.81
    rCSI 15.78%
    PRS 3.52
  • pancreatic ductal cell CL0002079
    CSI 15.77
    rCSI 30.67%
    PRS 4.25
  • myofibroblast cell CL0000186
    CSI 15.52
    rCSI 21.49%
    PRS 5.99
  • epithelial cell of lower respiratory tract CL0002632
    CSI 15.24
    rCSI 11.81%
    PRS 3.96
  • glandular epithelial cell CL0000150
    CSI 15.13
    rCSI 39.82%
    PRS 8.13
  • progenitor cell CL0011026
    CSI 15.08
    rCSI 32.08%
    PRS 8.04
  • tuft cell of colon CL0009041
    CSI 14.56
    rCSI 33.92%
    PRS 10.21
  • paneth cell of epithelium of small intestine CL1000343
    CSI 14.17
    rCSI 39.7%
    PRS 6.55
  • bronchus fibroblast of lung CL2000093
    CSI 14.04
    rCSI 11.41%
    PRS 4.37
  • melanocyte CL0000148
    CSI 14.03
    rCSI 10.39%
    PRS 3.91
  • respiratory basal cell CL0002633
    CSI 13.97
    rCSI 14.47%
    PRS 4.89
  • vascular leptomeningeal cell CL4023051
    CSI -17.2
    rCSI -30.2%
    PRS 3.3%
  • platelet CL0000233
    CSI -12.4
    rCSI -51.3%
    PRS 12.5%
  • ependymal cell CL0000065
    CSI -9.5
    rCSI -19.3%
    PRS 1.4%
  • epithelial cell of proximal tubule CL0002306
    CSI -7.2
    rCSI -17.5%
    PRS 4.3%
  • brain vascular cell CL4023072
    CSI -6.6
    rCSI -68.1%
    PRS 4.1%
  • retinal bipolar neuron CL0000748
    CSI -6.2
    rCSI -11.6%
    PRS 3.3%
  • neural cell CL0002319
    CSI -5.5
    rCSI -20.7%
    PRS 8.9%
  • brush cell of tracheobronchial tree CL0002075
    CSI -4.3
    rCSI -12.6%
    PRS 7.1%
  • sst GABAergic cortical interneuron CL4023017
    CSI -4.1
    rCSI -5.3%
    PRS 2.7%
  • astrocyte of the cerebral cortex CL0002605
    CSI -3.8
    rCSI -8.5%
    PRS 2.7%
  • tracheobronchial smooth muscle cell CL0019019
    CSI -3.6
    rCSI -6.4%
    PRS 5.5%
  • squamous epithelial cell CL0000076
    CSI -3.6
    rCSI -8.5%
    PRS 5.6%
  • dopaminergic neuron CL0000700
    CSI -3.4
    rCSI -19.3%
    PRS 1.3%
  • inhibitory interneuron CL0000498
    CSI -3.4
    rCSI -7.9%
    PRS 3.8%
  • parietal cell CL0000162
    CSI -3.3
    rCSI -28.8%
    PRS 28.6%
  • airway submucosal gland duct basal cell CL4033024
    CSI -3.3
    rCSI -20.8%
    PRS 19.9%
  • cerebral cortex neuron CL0010012
    CSI -3.2
    rCSI -13.1%
    PRS 5.2%
  • endocardial cell CL0002350
    CSI -3.1
    rCSI -15.0%
    PRS 7.1%
  • contractile cell CL0000183
    CSI -3.1
    rCSI -9.1%
    PRS 3.3%
  • renal alpha-intercalated cell CL0005011
    CSI -2.9
    rCSI -3.9%
    PRS 5.7%
  • adipocyte CL0000136
    CSI -2.8
    rCSI -3.6%
    PRS 5.2%
  • L4 intratelencephalic projecting glutamatergic neuron CL4030063
    CSI -2.5
    rCSI -6.1%
    PRS 2.4%
  • cardiac neuron CL0010022
    CSI -2.4
    rCSI -7.7%
    PRS 3.2%
  • pulmonary alveolar type 1 cell CL0002062
    CSI -2.3
    rCSI -13.3%
    PRS 6.3%
  • naive T cell CL0000898
    CSI -2.2
    rCSI -1.5%
    PRS 6.1%
  • endothelial cell of periportal hepatic sinusoid CL0019021
    CSI -1.8
    rCSI -8.4%
    PRS 15.7%
  • lung pericyte CL0009089
    CSI -1.8
    rCSI -4.8%
    PRS 5.0%
  • subcutaneous adipocyte CL0002521
    CSI -1.6
    rCSI -8.4%
    PRS 2.7%
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI -1.6
    rCSI -1.3%
    PRS 7.8%
  • lung neuroendocrine cell CL1000223
    CSI -1.4
    rCSI -2.0%
    PRS 4.8%
  • cerebellar neuron CL1001611
    CSI -1.3
    rCSI -11.4%
    PRS 1.2%
  • VIP GABAergic cortical interneuron CL4023016
    CSI -1.2
    rCSI -1.5%
    PRS 2.5%
  • exhausted T cell CL0011025
    CSI -1.2
    rCSI -20.3%
    PRS 21.7%
  • pericyte CL0000669
    CSI -1.1
    rCSI -3.0%
    PRS 27.4%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI -1.0
    rCSI -2.5%
    PRS 5.0%
  • cytotoxic T cell CL0000910
    CSI -0.9
    rCSI -4.9%
    PRS 6.5%
  • periportal region hepatocyte CL0019026
    CSI -0.8
    rCSI -3.2%
    PRS 6.9%
  • cord blood hematopoietic stem cell CL2000095
    CSI -0.8
    rCSI -15.4%
    PRS 34.8%
  • erythrocyte CL0000232
    CSI -0.7
    rCSI -1.7%
    PRS 6.0%
  • diffuse bipolar 3b cell CL4033030
    CSI -0.6
    rCSI -4.3%
    PRS 7.2%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI -0.4
    rCSI -1.2%
    PRS 6.1%
  • Kupffer cell CL0000091
    CSI -0.2
    rCSI -0.5%
    PRS 4.0%
  • hepatic pit cell CL2000054
    CSI -0.2
    rCSI -2.5%
    PRS 42.9%
  • L5/6 near-projecting glutamatergic neuron CL4030067
    CSI -0.2
    rCSI -0.6%
    PRS 2.3%
  • glycinergic amacrine cell CL4030028
    CSI -0.2
    rCSI -0.4%
    PRS 5.6%
  • diffuse bipolar 3a cell CL4033029
    CSI -0.1
    rCSI -0.6%
    PRS 7.2%
  • smooth muscle cell of the pulmonary artery CL0002591
    CSI 0.0
    rCSI -0.3%
    PRS 24.0%
  • medium spiny neuron CL1001474
    CSI 0.0
    rCSI 0.1%
    PRS 0.6%
  • ventricular cardiac muscle cell CL2000046
    CSI 0.1
    rCSI 0.4%
    PRS 19.1%
  • epithelial cell of esophagus CL0002252
    CSI 0.1
    rCSI 1.2%
    PRS 17.1%
  • eye photoreceptor cell CL0000287
    CSI 0.2
    rCSI 2.4%
    PRS 14.9%
  • kidney loop of Henle epithelial cell CL1000909
    CSI 0.3
    rCSI 5.8%
    PRS 36.0%
  • macroglial cell CL0000126
    CSI 0.3
    rCSI 0.8%
    PRS 7.5%
  • pancreatic epsilon cell CL0005019
    CSI 0.3
    rCSI 1.6%
    PRS 10.5%
  • neuroendocrine cell CL0000165
    CSI 0.3
    rCSI 1.3%
    PRS 9.0%
  • regular ventricular cardiac myocyte CL0002131
    CSI 0.4
    rCSI 2.4%
    PRS 3.5%
  • H1 horizontal cell CL0004217
    CSI 0.4
    rCSI 1.6%
    PRS 9.6%
  • lung goblet cell CL1000143
    CSI 0.4
    rCSI 4.4%
    PRS 13.9%
  • type B pancreatic cell CL0000169
    CSI 0.4
    rCSI 1.0%
    PRS 3.9%
  • epithelial cell of urethra CL1000296
    CSI 0.5
    rCSI 11.9%
    PRS 14.9%
  • vasa recta descending limb cell CL1001285
    CSI 0.5
    rCSI 4.0%
    PRS 19.0%
  • IgM plasma cell CL0000986
    CSI 0.5
    rCSI 2.4%
    PRS 22.6%
  • skeletal muscle satellite stem cell CL0008011
    CSI 0.5
    rCSI 2.3%
    PRS 16.8%
  • H2 horizontal cell CL0004218
    CSI 0.5
    rCSI 2.6%
    PRS 6.7%
  • regular atrial cardiac myocyte CL0002129
    CSI 0.5
    rCSI 1.7%
    PRS 5.0%
  • renal interstitial pericyte CL1001318
    CSI 0.5
    rCSI 1.5%
    PRS 4.8%
  • antibody secreting cell CL0000946
    CSI 0.6
    rCSI 2.6%
    PRS 19.4%
  • smooth muscle cell of prostate CL1000487
    CSI 0.6
    rCSI 3.5%
    PRS 23.4%
  • fibroblast of cardiac tissue CL0002548
    CSI 0.6
    rCSI 3.1%
    PRS 2.4%
  • diffuse bipolar 6 cell CL4033032
    CSI 0.7
    rCSI 3.4%
    PRS 8.6%
  • double negative T regulatory cell CL0011024
    CSI 0.7
    rCSI 12.7%
    PRS 35.7%
  • mesenchymal stem cell of adipose tissue CL0002570
    CSI 0.7
    rCSI 3.7%
    PRS 15.7%
  • neuroplacodal cell CL0000032
    CSI 0.7
    rCSI 6.2%
    PRS 16.2%
  • NKp44-negative group 3 innate lymphoid cell, human CL0001080
    CSI 0.7
    rCSI 21.5%
    PRS 50.7%
  • podocyte CL0000653
    CSI 0.7
    rCSI 3.2%
    PRS 4.2%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 0.7
    rCSI 1.8%
    PRS 3.3%
  • professional antigen presenting cell CL0000145
    CSI 0.8
    rCSI 2.6%
    PRS 19.1%
  • Purkinje cell CL0000121
    CSI 0.8
    rCSI 9.8%
    PRS 36.8%
  • acinar cell of salivary gland CL0002623
    CSI 0.8
    rCSI 18.0%
    PRS 5.6%
  • forebrain neuroblast CL1000042
    CSI 0.8
    rCSI 8.4%
    PRS 53.1%
  • decidual natural killer cell, human CL0002343
    CSI 0.9
    rCSI 8.7%
    PRS 38.0%
  • serous secreting cell of bronchus submucosal gland CL4033005
    CSI 0.9
    rCSI 5.0%
    PRS 22.9%
  • neuron CL0000540
    CSI 0.9
    rCSI 2.5%
    PRS 4.5%
  • invaginating midget bipolar cell CL4033034
    CSI 1.0
    rCSI 5.6%
    PRS 7.2%
  • cerebral cortex pyramidal neuron CL4023111
    CSI 1.0
    rCSI 6.4%
    PRS 15.9%
  • cell of skeletal muscle CL0000188
    CSI 1.1
    rCSI 12.0%
    PRS 29.0%
  • tissue-resident macrophage CL0000864
    CSI 1.2
    rCSI 5.4%
    PRS 11.7%
  • midzonal region hepatocyte CL0019028
    CSI 1.2
    rCSI 2.7%
    PRS 7.3%
  • cerebellar granule cell CL0001031
    CSI 1.2
    rCSI 1.7%
    PRS 4.3%
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 1.2
    rCSI 12.8%
    PRS 21.0%
  • plasma cell CL0000786
    CSI 1.2
    rCSI 1.6%
    PRS 22.5%
  • corneal epithelial cell CL0000575
    CSI 1.3
    rCSI 3.6%
    PRS 8.1%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 1.3
    rCSI 1.8%
    PRS 9.0%
  • kidney distal convoluted tubule epithelial cell CL1000849
    CSI 1.3
    rCSI 13.8%
    PRS 7.1%
  • mesangial cell CL0000650
    CSI 1.3
    rCSI 5.4%
    PRS 7.2%
  • lung interstitial macrophage CL4033043
    CSI 1.4
    rCSI 3.0%
    PRS 10.6%
  • retinal cone cell CL0000573
    CSI 1.4
    rCSI 2.2%
    PRS 3.2%
  • renal beta-intercalated cell CL0002201
    CSI 1.4
    rCSI 3.3%
    PRS 5.4%
  • B-2 B cell CL0000822
    CSI 1.4
    rCSI 29.1%
    PRS 26.9%
  • duct epithelial cell CL0000068
    CSI 1.4
    rCSI 2.0%
    PRS 4.4%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [FUS](/details-gene/2521) (FUS RNA binding protein) is a multifunctional protein primarily involved in RNA processing, transcription regulation, and DNA damage repair. As a key component of ribonucleoprotein complexes, it plays a central role in RNA splicing, as detailed in Reactome pathways like [Mrna splicing - major pathway](https://reactome.org/content/detail/R-HSA-72163), and mRNA stabilization ([GO:0048255](https://www.ebi.ac.uk/QuickGO/term/GO:0048255)). The gene's activity is particularly significant in highly proliferative cells, including [hematopoietic stem cell](/details-cell/CL0000037)s and various immune progenitors, as well as in regenerative epithelial tissues. Clinically, mutations in [FUS](/details-gene/2521) are linked to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) ([153245](https://omim.org/entry/153245)), and chromosomal translocations involving [FUS](/details-gene/2521) generate oncogenic fusion proteins implicated in various sarcomas and leukemias [Link](https://doi.org/10.1038/363640a0) [Link](https://pubmed.ncbi.nlm.nih.gov/8187069/). ## Cellular Roles and Expression Landscape **Overall**, the expression profile of [FUS](/details-gene/2521) highlights its fundamental importance in cellular proliferation and differentiation, particularly within the hematopoietic system. It exhibits high significance scores in primitive cell types, including [hematopoietic stem cell](/details-cell/CL0000037) (CSI: 90.81), [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) (CSI: 86.27), and [common myeloid progenitor](/details-cell/CL0000049) (CSI: 79.64). Its importance extends to committed lymphoid lineages, with high significance in [CD4-positive helper T cell](/details-cell/CL0000492)s and progenitor B cells such as [fraction A pre-pro B cell](/details-cell/CL0002045). Beyond the immune system, [FUS](/details-gene/2521) is also a key gene in actively cycling epithelial tissues, evidenced by its high scores in [fallopian tube secretory epithelial cell](/details-cell/CL4030006) (CSI: 80.28) and [keratinocyte](/details-cell/CL0000312) (CSI: 72.15). Conversely, [FUS](/details-gene/2521) shows markedly low significance in many terminally differentiated and non-proliferative cell types. This pattern is particularly evident in the nervous system, with negative CSI scores in [retinal bipolar neuron](/details-cell/CL0000748), [dopaminergic neuron](/details-cell/CL0000700), and [astrocyte of the cerebral cortex](/details-cell/CL0002605). This low baseline expression in healthy neurons, despite its strong association with neurodegeneration, suggests that its function may be under extremely tight regulation or highly localized within specific subcellular compartments, such as synapses. Its low significance in anucleated [platelet](/details-cell/CL0000233)s is consistent with its primary nuclear and RNA-processing roles. ## Pathways and Molecular Function The molecular functions of [FUS](/details-gene/2521) are centered on its ability to bind RNA ([GO:0003723](https://www.ebi.ac.uk/QuickGO/term/GO:0003723)) and DNA ([GO:0003677](https://www.ebi.ac.uk/QuickGO/term/GO:0003677)), enabling its participation in a wide array of nuclear processes. It is a core component of the spliceosome, contributing to both major and minor pathway [mRNA splicing](https://reactome.org/content/detail/R-HSA-72172), a role essential for gene expression regulation in all analyzed cell types. Beyond splicing, [FUS](/details-gene/2521) is involved in maintaining genomic stability through its role in the [positive regulation of double-strand break repair via homologous recombination](https://www.ebi.ac.uk/QuickGO/term/GO:1905168) [Link](https://doi.org/10.1042/bj20081135). This function is critical in progenitor cells that undergo frequent division. Furthermore, its capacity for [molecular condensate scaffold activity](https://www.ebi.ac.uk/QuickGO/term/GO:0140693) allows it to assemble into [intracellular non-membrane-bounded organelle](https://www.ebi.ac.uk/QuickGO/term/GO:0043232)s, such as stress granules, which regulate mRNA translation during cellular stress. Although its overall expression is low in neurons, its annotated presence in the [glutamatergic synapse](/details-cell/CL0000811) ([GO:0098978](https://www.ebi.ac.uk/QuickGO/term/GO:0098978)) and [GABA-ergic synapse](https://www.ebi.ac.uk/QuickGO/term/CL0000811) ([GO:0098982](https://www.ebi.ac.uk/QuickGO/term/GO:0098982)) points to a specialized role in local protein synthesis and RNA transport at these sites, which may be disrupted in disease states. ## Research Directions The data suggest several avenues for future investigation into the pleiotropic roles of [FUS](/details-gene/2521). **Proposed Hypotheses:** 1. Given its high significance in hematopoietic progenitors, it is hypothesized that [FUS](/details-gene/2521) acts as a master regulator of hematopoietic lineage commitment by controlling the alternative splicing of key transcription factors and cell fate determinants. Its disruption may lead to skewed differentiation and hematopoietic malignancies. 2. The disparity between low overall neuronal expression and its critical role in ALS ([137070](https://omim.org/entry/137070)) suggests that the primary pathogenic mechanism involves the disruption of its localized functions. We hypothesize that ALS-associated mutations in [FUS](/details-gene/2521) impair its ability to scaffold synaptic RNA granules, leading to aberrant local translation and synaptic dysfunction, which precedes overt neurodegeneration. **Key Experimental Approach:** To test the second hypothesis, one could utilize human iPSC-derived motor neurons harboring pathogenic [FUS](/details-gene/2521) mutations. A combination of advanced techniques would be powerful: * **Proximity-labeling mass spectrometry** (e.g., APEX2-FUS) could be employed to identify the specific RNA and protein interactome of mutant vs. wild-type [FUS](/details-gene/2521) within dendritic and axonal compartments. * **Super-resolution imaging** would allow for the direct visualization of [FUS](/details-gene/2521)-containing granules, assessing their morphology, dynamics, and colocalization with synaptic markers. * **Functional assays**, such as measuring local protein synthesis via puromycylation assays in neurites, would directly test the impact of mutations on synaptic translation. **Therapeutic Potential:** The ubiquitous and essential nature of [FUS](/details-gene/2521) makes it a challenging therapeutic target for systemic inhibition. For cancers driven by [FUS](/details-gene/2521) translocations, therapeutic strategies should focus on inhibiting the neomorphic function of the specific fusion oncoprotein rather than wild-type [FUS](/details-gene/2521). In the context of ALS, the therapeutic goal would be corrective. This could involve developing allele-specific antisense oligonucleotides (ASOs) to selectively lower the expression of the mutant protein or designing small molecules that prevent its cytoplasmic mislocalization and aggregation, thereby restoring its normal function and mitigating cellular toxicity.

Genular Protein ID: 2865356190

Symbol: FUS_HUMAN

Name: RNA-binding protein FUS

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 8510758

Title: Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.

PubMed ID: 8510758

DOI: 10.1038/363640a0

PubMed ID: 7503811

Title: Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma.

PubMed ID: 7503811

DOI: 10.1038/ng0693-175

PubMed ID: 9795213

Title: Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.

PubMed ID: 9795213

DOI: 10.1016/s0378-1119(98)00463-6

PubMed ID: 15616553

Title: The sequence and analysis of duplication-rich human chromosome 16.

PubMed ID: 15616553

DOI: 10.1038/nature03187

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 11063792

Title: Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11.

PubMed ID: 11063792

DOI: 10.1016/s0165-4608(00)00237-5

PubMed ID: 10567410

Title: Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation.

PubMed ID: 10567410

DOI: 10.1074/jbc.274.48.34337

PubMed ID: 10442642

Title: Human POMp75 is identified as the pro-oncoprotein TLF/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation.

PubMed ID: 10442642

DOI: 10.1038/sj.onc.1203048

PubMed ID: 8187069

Title: An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation.

PubMed ID: 8187069

PubMed ID: 9660765

Title: The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription.

PubMed ID: 9660765

DOI: 10.1074/jbc.273.29.18086

PubMed ID: 9774382

Title: Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing.

PubMed ID: 9774382

DOI: 10.1074/jbc.273.43.27761

PubMed ID: 12964758

Title: Detection of arginine dimethylated peptides by parallel precursor ion scanning mass spectrometry in positive ion mode.

PubMed ID: 12964758

DOI: 10.1021/ac026283q

PubMed ID: 17196963

Title: Intracellular characterization of DDX39, a novel growth-associated RNA helicase.

PubMed ID: 17196963

DOI: 10.1016/j.yexcr.2006.11.014

PubMed ID: 18632687

Title: TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules.

PubMed ID: 18632687

DOI: 10.1093/hmg/ddn203

PubMed ID: 18620545

Title: Identification and characterization of FUS/TLS as a new target of ATM.

PubMed ID: 18620545

DOI: 10.1042/bj20081135

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 22814378

Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

PubMed ID: 22814378

DOI: 10.1073/pnas.1210303109

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24204307

Title: ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation.

PubMed ID: 24204307

DOI: 10.1371/journal.pgen.1003895

PubMed ID: 25453086

Title: Self-assembled FUS binds active chromatin and regulates gene transcription.

PubMed ID: 25453086

DOI: 10.1073/pnas.1414004111

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 24129315

Title: Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.

PubMed ID: 24129315

DOI: 10.1074/mcp.o113.027870

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 27615052

Title: A novel missense mutation of CMT2P alters transcription machinery.

PubMed ID: 27615052

DOI: 10.1002/ana.24776

PubMed ID: 26124092

Title: FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP.

PubMed ID: 26124092

DOI: 10.1073/pnas.1506282112

PubMed ID: 27731383

Title: FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription.

PubMed ID: 27731383

DOI: 10.1038/srep35195

PubMed ID: 28112733

Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

PubMed ID: 28112733

DOI: 10.1038/nsmb.3366

PubMed ID: 29897835

Title: The prionlike domain of FUS is multiphosphorylated following DNA damage without altering nuclear localization.

PubMed ID: 29897835

DOI: 10.1091/mbc.e17-12-0735

PubMed ID: 30354839

Title: The hnRNP raly regulates PRMT1 expression and interacts with the ALS-linked protein FUS: implication for reciprocal cellular localization.

PubMed ID: 30354839

DOI: 10.1091/mbc.e18-02-0108

PubMed ID: 16959974

Title: The consensus coding sequences of human breast and colorectal cancers.

PubMed ID: 16959974

DOI: 10.1126/science.1133427

PubMed ID: 19251627

Title: Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.

PubMed ID: 19251627

DOI: 10.1126/science.1166066

PubMed ID: 19251628

Title: Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.

PubMed ID: 19251628

DOI: 10.1126/science.1165942

PubMed ID: 19861302

Title: Mutations of FUS gene in sporadic amyotrophic lateral sclerosis.

PubMed ID: 19861302

DOI: 10.1136/jmg.2009.071027

PubMed ID: 20124201

Title: Genetic contribution of FUS to frontotemporal lobar degeneration.

PubMed ID: 20124201

DOI: 10.1212/wnl.0b013e3181ccc732

PubMed ID: 22863194

Title: Exome sequencing identifies fus mutations as a cause of essential tremor.

PubMed ID: 22863194

DOI: 10.1016/j.ajhg.2012.07.002

PubMed ID: 27604643

Title: Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China.

PubMed ID: 27604643

DOI: 10.1038/srep32478

Sequence Information:

  • Length: 526
  • Mass: 53426
  • Checksum: 88C8E263B7905549
  • Sequence:
  • MASNDYTQQA TQSYGAYPTQ PGQGYSQQSS QPYGQQSYSG YSQSTDTSGY GQSSYSSYGQ 
    SQNTGYGTQS TPQGYGSTGG YGSSQSSQSS YGQQSSYPGY GQQPAPSSTS GSYGSSSQSS 
    SYGQPQSGSY SQQPSYGGQQ QSYGQQQSYN PPQGYGQQNQ YNSSSGGGGG GGGGGNYGQD 
    QSSMSSGGGS GGGYGNQDQS GGGGSGGYGQ QDRGGRGRGG SGGGGGGGGG GYNRSSGGYE 
    PRGRGGGRGG RGGMGGSDRG GFNKFGGPRD QGSRHDSEQD NSDNNTIFVQ GLGENVTIES 
    VADYFKQIGI IKTNKKTGQP MINLYTDRET GKLKGEATVS FDDPPSAKAA IDWFDGKEFS 
    GNPIKVSFAT RRADFNRGGG NGRGGRGRGG PMGRGGYGGG GSGGGGRGGF PSGGGGGGGQ 
    QRAGDWKCPN PTCENMNFSW RNECNQCKAP KPDGPGGGPG GSHMGGNYGD DRRGGRGGYD 
    RGGYRGRGGD RGGFRGGRGG GDRGGFGPGK MDSRGEHRQD RRERPY

Genular Protein ID: 3825298007

Symbol: Q13344_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Sequence Information:

  • Length: 528
  • Mass: 53377
  • Checksum: 43CFD6CBDA57A258
  • Sequence:
  • MASNDYTQQA TQSYGAYPTQ PGQGYSQQSS QPYGQQSYSG YSQSTDTGYG QSSYSSYGQS 
    QNTGYGTQSA PQGYGSTGGY GSSQSSQSSY GQQSSYPGYG PQPTPSSTSG SYGSSSQTSS 
    YGQPPSYGQQ PSYGGQQQSY GQQQSYNPSG YGQQNQYNSS SSGSGGGGSY GQDQSSMSGS 
    GGGGGGGGGG GSGGGGGYGN QDQSGGGGGG YGQQDRGGRG RGRSSGGGGG SGGGYNRSSG 
    GYEPRGRGGG RGGRGGMGGS DRGGFNKFGG PRDQGSRHDS EQDNSDNNTI FVQGLGENVT 
    IESVADYFKQ IGIIKTNKKT GQPMINLYTD RETGKLKGEA TVSFDDPPSA KAAIDWFDGK 
    EFSGNPIKVS FATRRADFNR GGGNGRGGRG RGGPMGRGGY GGGGSGGGGR GGFPSGGGGG 
    GGQQRAGDWK CPNPTCENMN FSWRNECNQC KAPKPDGPGG GPGGSHMGGN YGDDRRGGRG 
    GYDRGGYRGR GGDRGGFRGG RGGGDRGGFG PGKMDSRGEH RQDRRERP